Skip to main content

Regenerx Biopharmaceuticals Inc

RGRXDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0000707511

Regenerx Biopharmaceuticals Inc was delisted in 2023; its insiders filed their last Form 4 on Jul 6, 2023; 1 institution reported holding it in 13F filings for Q3 2023, worth $170 in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Regenerx Biopharmaceuticals Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of RGRX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders110
Shares210.0K210.0K0 (0.0%)
Value$35.0K$34.0K−$1.00K (−2.9%)

New holders (0)

Institutions that held Regenerx Biopharmaceuticals Inc at the end of Q4 2021 but not at the end of Q3 2021.

None.

Sold out (0)

Institutions that held Regenerx Biopharmaceuticals Inc at the end of Q3 2021 and filed for Q4 2021 without it.

None.